RxDoctor Payments DataLook up a doctor →

Lawrence Lavery

Foot Surgery · San Antonio, TXNPI 1992765655

Payments from drug & device makers

$1,154,007in general payments, 2019–2025

Across 324 payments — averaging $3561.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotissue Holdings Inc.$550K
  • Smith+Nephew$301K
  • AstraZeneca$132K
  • Integra Lifesciences Corporation$58K
  • Osiris Therapeutics Inc.$41K
  • Acera Surgical, Inc.$19K
  • plus $54K from 24 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,154,007 in reported general payments places this provider in the 95th percentile of 71 foot surgery providers in Texas.

See all foot surgery providers in Texas

Medicare billing

Part B allowed, 2024
$60,829
Medicare patients
130
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot surgery in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →